Wikidata

(Q48818299)

English

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial.

scientific article published on 11 May 2010

In more languages

Statements

title
Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20462664
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20462664%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q48818299&oldid=1238960772"